Passage Bio Inc (PASG)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $13.68M
Last updated: Nov 17, 2026 at 11:06 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 0.8% above its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 56.9, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about PASG
News
PASG Valuation
- P/B
- 265.8x
PASG Profitability: Margins, ROIC and FCF
Passage Bio (PASG) has an operating margin of 0.0% and a net margin of 0.0%.
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROE
- -212.3%
Passage Bio Competitors
The companies most similar to Passage Bio (PASG) include Psyence Biomedical Ltd. Common Shares, Cyclerion Therapeutics and Biovie.
Sector: Healthcare
Companies most similar to Passage BioPASG Analyst Ratings
Passage Bio (PASG) has a Hold consensus from 3 analysts: 1 Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell.
- Consensus
- Hold
- Analysts
- 3
- Strong Buy
- 0
- Buy
- 1
- Hold
- 2
- Sell
- 0
- Strong Sell
- 0
PASG Earnings: Beat Rate and Next Report
Passage Bio (PASG) beat the EPS estimate in 4 of the last 8 quarters (50.0%). Its next report is expected on Mar 1, 2027.
- Beat rate
- 4 of 8 quarters (50.0%)
- Average surprise
- 5.0%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$2.60
PASG Earnings Date
PASG reports Mar 1, 2027. The date is estimated.
PASG ETF Holders
GNG tracks 2 ETFs that hold PASG. The largest weights:
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Updated Nov 10, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About PASG
When does PASG report earnings?
Passage Bio Inc (PASG) is expected to report earnings on Mar 1, 2027.
Does PASG pay dividends?
Passage Bio Inc (PASG) does not currently pay a regular dividend.
What is PASG's market cap?
Passage Bio Inc (PASG) has a market capitalization of $13.68M with a current stock price of $4.13.
PASG pages: Overview, Earnings, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.